This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| INTL CONSOLIDATED AIRLINE-DI | 121.6 | 5.5% |
| CENTRICA PLC | 76.6 | 4.7% |
| NATWEST GROUP PLC | 234.8 | 4.4% |
| FLUTTER ENTERTAINMENT PLC-DI | 11,580.0 | 3.0% |
| COCA-COLA HBC AG-DI | 1,902.5 | 2.7% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| INTERTEK GROUP PLC | 3654.0 | -2.8% |
| CRODA INTERNATIONAL PLC | 6760.0 | -1.5% |
| MONDI PLC | 1462.5 | -1.5% |
| RS GROUP PLC | 958.5 | -1.4% |
| SPIRAX-SARCO ENGINEERING PLC | 10750.0 | -1.4% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,144 | -0.6% | -1.5% |
| DOW JONES INDUS. AVG | 32,148 | -1.6% | -11.1% |
| DAX INDEX | 13,257 | -0.6% | -16.9% |
| NIKKEI 225 | 27,663 | -0.1% | -6.3% |
| S&P/ASX 200 INDEX | 6,858 | -1.8% | -7.2% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 89.09 | -1.01% |
| Brent Crude (ICE) | USD/bbl. | 95.39 | -0.80% |
| Gold Spot | USD/t oz. | 1,630 | -0.3% |
| Copper (Comex) | USd/lb. | 344 | -0.8% |
Click graph to enlarge
The UK 100 is called to open -37 points this morning at 7107. The UK 100 looks set to open lower this morning following yesterdays Federal reserve interest rate increase of 0.75%, the rise was in-line with expectations however, US markets fell back sharply after Fed chair Jerome Powell signalled further hikes were on the way: "We have a ways to go," before rate hikes could be paused. The Dow closed Wednesday down 505 points, 1.6%, at 32,148, the Nasdaq slipped 366, 3.4%, to 10,525 and the S&P lost 97 points, 2.5%, to 3,760. Focus will now shift to the Bank of England who will announce its interest rate decision at noon with expectations of a 75bp increase to match the Fed although some analysts suggest the recent poor economic data may prompt a lower increase.
BT Group have increased their savings target by £500m to help fund the rising cost of building its fibre network as it met forecasts in H1. They reported a revenue of £10.4bn (+1% due to growth in its consumer and Openreach units) with core earnings of £3.9bn, +3% in H1.
Hikma Pharmaceuticals sees their FY generics revenue to be in the range of $650-675m as their search for a new CEO remains on track.
Rolls-Royce says FY22 guidance remains unchanged as market volatility hasn't impacted cash flows. They have received $1.8bn in contract renewals amid "robust demand" but state that defence revenue growth in 2022 is expected to be "modest" due to non-repeats.
Sainsbury's kept its financial guidance for the year despite reporting an 8% fall in H1 profit. They still expect a 2022-23 underlying pretax profit of between 630-690m, down from the £730m made in 2021-22. Prior to the update analysts were on average forecasting £637m.
Smith & Nephew report revenue for Q3 of $1.25bn, down from $1.27bn in 2021. They state that FY underlying revenue growth is expected in the range of 4-5%. They also repeat their unchanged trading profit margin guidance of around 18%.
No new broker comments
BT Group
Helios Towers
Hikma Pharmaceuticals
Sainsbury
Smith & Nephew
Trainline
Aston Martin Lagonda
Chinese Caixin Services PMI
UK S&P Global/CIPS Composite PMI
EU Unemployment Rate
Bank of England Minutes
Bank of England Monetary Policy Report
BoE Asset Purchase Facility
BoE Interest Rate Decision
BoE Monetary Policy Summary
US Goods and Services Trade Balance
US Initial Jobless Claims
BoE's Governor Bailey speech
US S&P Global Composite PMI
US S&P Global Services PMI
US ISM Services PMI
UK 100 companies going ex-dividend on 3rd November 2022:
None
UK 250 companies going ex-dividend on 3rd November 2022:
Ashmore Group
GCP Infrastructure Investments
VinaCapital Vietnam Opportunity Fund
Renishaw
Hilton Food Group
Edinburgh Investment Trust
European Opportunities Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.